These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 19149763)

  • 1. Treatment of colorectal liver metastases: a review.
    Van den Eynde M; Hendlisz A
    Rev Recent Clin Trials; 2009 Jan; 4(1):56-62. PubMed ID: 19149763
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integration of neoadjuvant and adjuvant chemotherapy in patients with resectable liver metastases from colorectal cancer.
    Hebbar M; Pruvot FR; Romano O; Triboulet JP; de Gramont A
    Cancer Treat Rev; 2009 Dec; 35(8):668-75. PubMed ID: 19733977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postoperative hepatic arterial chemotherapy in high-risk patients as adjuvant treatment after resection of colorectal liver metastases - a randomized phase II/III trial - PACHA-01 (NCT02494973).
    Goéré D; Pignon JP; Gelli M; Elias D; Benhaim L; Deschamps F; Caramella C; Boige V; Ducreux M; de Baere T; Malka D
    BMC Cancer; 2018 Aug; 18(1):787. PubMed ID: 30081865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. R1 resection for aggressive or advanced colorectal liver metastases is justified in combination with effective prehepatectomy chemotherapy.
    Tanaka K; Nojiri K; Kumamoto T; Takeda K; Endo I
    Eur J Surg Oncol; 2011 Apr; 37(4):336-43. PubMed ID: 21277151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged survival of initially unresectable hepatic colorectal cancer patients treated with hepatic arterial infusion of oxaliplatin followed by radical surgery of metastases.
    Goéré D; Deshaies I; de Baere T; Boige V; Malka D; Dumont F; Dromain C; Ducreux M; Elias D
    Ann Surg; 2010 Apr; 251(4):686-91. PubMed ID: 20224373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adjuvant chemotherapy after resection of colorectal liver metastases in patients at high risk of hepatic recurrence: a comparative study between hepatic arterial infusion of oxaliplatin and modern systemic chemotherapy.
    Goéré D; Benhaim L; Bonnet S; Malka D; Faron M; Elias D; Lefèvre JH; Deschamps F; Dromain C; Boige V; Dumont F; De Baere T; Ducreux M
    Ann Surg; 2013 Jan; 257(1):114-20. PubMed ID: 23235397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment with 5-fluorouracil/folinic acid, oxaliplatin, and irinotecan enables surgical resection of metastases in patients with initially unresectable metastatic colorectal cancer.
    Masi G; Cupini S; Marcucci L; Cerri E; Loupakis F; Allegrini G; Brunetti IM; Pfanner E; Viti M; Goletti O; Filipponi F; Falcone A
    Ann Surg Oncol; 2006 Jan; 13(1):58-65. PubMed ID: 16372158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Place of hepatic intra-arterial chemotherapy in the treatment of colorectal liver metastases.
    Allard MA; Malka D
    J Visc Surg; 2014 Apr; 151 Suppl 1():S21-4. PubMed ID: 24636278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent results of irinotecan therapy in colorectal cancer].
    Láng I; Hitre E
    Magy Onkol; 2004; 48(4):281-8. PubMed ID: 15655572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regional chemotherapy for liver-limited metastatic colorectal cancer.
    Power DG; Healey-Bird BR; Kemeny NE
    Clin Colorectal Cancer; 2008 Jul; 7(4):247-59. PubMed ID: 18650193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases.
    Adam R
    Ann Oncol; 2003; 14 Suppl 2():ii13-6. PubMed ID: 12810452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OncoSurge: a strategy for long-term survival in metastatic colorectal cancer.
    Alberts S; Poston G
    Colorectal Dis; 2003 Nov; 5 Suppl 3():20-8. PubMed ID: 23573557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of hepatic metastases from colorectal cancer: many doubts, some certainties.
    Biasco G; Derenzini E; Grazi G; Ercolani G; Ravaioli M; Pantaleo MA; Brandi G
    Cancer Treat Rev; 2006 May; 32(3):214-28. PubMed ID: 16546323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective phase II trial of combination hepatic artery infusion and systemic chemotherapy for unresectable colorectal liver metastases: Long term results and curative potential.
    Pak LM; Kemeny NE; Capanu M; Chou JF; Boucher T; Cercek A; Balachandran VP; Kingham TP; Allen PJ; DeMatteo RP; Jarnagin WR; D'Angelica MI
    J Surg Oncol; 2018 Mar; 117(4):634-643. PubMed ID: 29165816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in neoadjuvant therapy for colorectal cancer with liver metastases.
    Pozzo C; Barone C; Kemeny NE
    Cancer Treat Rev; 2008 Jun; 34(4):293-301. PubMed ID: 18291590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of and future perspectives for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer.
    Sadahiro S; Suzuki T; Tanaka A; Okada K; Kamata H; Koisumi J
    Surg Today; 2013 Oct; 43(10):1088-94. PubMed ID: 23143145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncological management of unresectable liver metastases.
    Prenen H; Van Cutsem E
    Dig Dis; 2012; 30 Suppl 2():137-42. PubMed ID: 23207946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HEMIHEPATECTOMY FOR RESECTABLE HEPATIC METASTASIS FROM COLORECTAL CANCER WITH POOR PROGNOSIS].
    Patyutko YI; Kotelnikov AG; Mamontov KG; Podluzhny DV; Ponomarenko AA
    Vopr Onkol; 2015; 61(3):439-47. PubMed ID: 26242159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy and molecular-targeted treatment for unresectable hepatic metastases: a Japanese perspective.
    Shimada Y
    J Hepatobiliary Pancreat Sci; 2012 Sep; 19(5):515-22. PubMed ID: 22588204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dramatic tumor response of bulky liver metastases following treatment with CPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient.
    Gornet JM; Azoulay D; Lévi F; Yovine A; Misset JL; Goldwasser F
    Anticancer Drugs; 2000 Apr; 11(4):263-8. PubMed ID: 10898541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.